Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study-Reference-Cited by-同舟云学术

Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study

Published:2022-11 Issue:11 Volume:4 Page:100547
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Taliercio Jonathan J.,Nakhoul Georges,Mehdi Ali,Yang Wei,Sha Daohang,Schold Jesse D.,Kasner Scott,Weir Matthew,Hassanein Mohamed,Navaneethan Sankar D.,Krishnan Geetha,Kanthety Radhika,Go Alan S.,Deo Rajat,Lora Claudia M.,Jaar Bernard G.,Chen Teresa K.,Chen Jing,He Jiang,Rahman Mahboob,Appel Lawrence J.,Cohen Debbie L.,Feldman Harold I.,Lash James P.,Nelson Robert G.,Rao Panduranga S.,Shah Vallabh O.,Unruh Mark L.

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference50 articles.

1. 2019 ACC/AHA Guideline on the Primary prevention of cardiovascular disease: a report of the American college of cardiology/american heart association task force on clinical practice guidelines;Arnett;J Am Coll Cardiol,2019

2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

3. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease;Kidney Int Suppl,2013

4. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review;Konstantinidis;JAMA Intern Med,2016

5. Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era;Maini;J Am Soc Nephrol,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the impact of aspirin on patients with chronic kidney disease; a systematic review and meta-analysis;Journal of Renal Injury Prevention;2024-06-24

2. A Thorough Literature Review of the Potential Benefits and Drawbacks of Long-Term Aspirin Use for the Primary Prevention of Cardiovascular Disease;Cardiology in Review;2024-05-24

3. Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial;Therapeutic Apheresis and Dialysis;2024-03-12

4. Association of long-term aspirin use with kidney disease progression;Frontiers in Medicine;2023-12-04

5. Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy;Russian Journal of Transplantology and Artificial Organs;2023-11-13